ELElin Laxdal

Elin Laxdal

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Elin Laxdal has a total of 91 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Bone remodeling effect of a chitosan and calcium phosphate-based composite

    by Lilja Kjalarsdóttir, Arna Dýrfjörd, Atli Dagbjartsson, Elín H Laxdal, Gissur Örlygsson, Jóhannes Gíslason, Jón M Einarsson, Chuen-How Ng, Halldór Jónsson

    Chitosan is a biocompatible polymer that has been widely studied for tissue engineering purposes. The aim of this research was to assess bone regenerative properties of an injectable chitosan and calcium phosphate-based composite and identify optimal degree of deacetylation (%DDA) of the chitosan polymer. Drill holes were generated on the left side of a mandible in Sprague-Dawley rats, and the hole was either left empty or filled with the implant. The animals were sacrificed at several time points after surgery (7–22 days) and bone was investigated using micro-CT and histology. No significant new bone formation was observed in the implants themselves at any time points. However, substantial new bone formation was observed in the rat mandible further away from the drill hole. Morphological changes indicating bone formation were found in specimens explanted on Day 7 in animals that received implant. Similar bone formation pattern was seen in control animals with an empty drill hole at later time points but not to the same extent. A second experiment was performed to examine if the %DDA of the chitosan polymer influenced the bone remodeling response. The results suggest that chitosan polymers with %DDA between 50 and 70% enhance the natural bone remodeling mechanism.


  • Open Access

    Drep í fingrum í kjölfar ísetningar slagæðaleggja - sjúkratilfelli

    by Atli Steinn Valgarðsson, Sigurbergur Kárason, Elín Laxdal, Kristín Huld Haraldsdóttir

    Arterial cannulation is a common procedure in critically ill patients, as it facilitates continuous monitoring of blood pressure, titration of inotropes, vasopressors and fluids and is also used for blood sampling. Serious complications from arterial lines are very rare, permanent ischemic damage occurs in less than 0,1% of patients. We report the case of a 60-year-old woman in septic shock caused by a perforated duodenal ulcer which was treated with emergent laparoscopic repair. She required high doses of vasopressors and received several arterial lines, including lines in both the ulnar and the radial arteries of the left arm. After two weeks in the intensive care unit she developed ischemia in all fingers of her left hand. She received anticoagulative therapy which was complicated by serious gastrointestinal bleeding and the therapy had to be discontinued. Eight weeks later she had demarcated necrosis in all fingers of her left hand and underwent partial amputation of fingers II-V, the thumb recovered without surgery. The cause of the necrosis was believed to be arterial embolism or ischemia secondary to arte- rial cannulations in combination with her underlying critical septic condition.


  • The National Norwegian Carotid Study: Time from Symptom Onset to Surgery is too Long, Resulting in Additional Neurological Events

    by K.E. Kjørstad, S.T. Baksaas, D. Bundgaard, E. Halbakken, T. Hasselgård, T. Jonung, G.T. Jørgensen, J.J. Jørgensen, A.H. Krog, K. Krohg-Sørensen, et al.

  • Open Access

    Editor's Choice – The National Norwegian Carotid Study: Time from Symptom Onset to Surgery is too Long, Resulting in Additional Neurological Events

    by K.E. Kjørstad, S.T. Baksaas, D. Bundgaard, E. Halbakken, T. Hasselgård, T. Jonung, G.T. Jørgensen, J.J. Jørgensen, A.H. Krog, K. Krohg-Sørensen, et al.


  • Open Access

    Editor's Choice: Contemporary Treatment of Popliteal Artery Aneurysm in Eight Countries: A Report from the Vascunet Collaboration of Registries

    by M. Björck, B. Beiles, G. Menyhei, I. Thomson, P. Wigger, M. Venermo, E. Laxdal, G. Danielsson, T. Lees, T. Troëng


  • Open Access

    The Norwegian Stroke in the Young Study (NOR-SYS): Rationale and design

    by Annette Fromm, Lars Thomassen, Halvor Naess, Rudy Meijer, Geir Egil Eide, Jostein Kråkenes, Christian A Vedeler, Eva Gerdts, Terje H Larsen, Karel K-J Kuiper, et al.

    Ischemic stroke in young adults is a major health problem being associated with a higher vascular morbidity and mortality compared to controls, and a stroke recurrence rate of 25% during the first decade. The assumed cause of infarction and the detected risk factors determine the early- and long-term treatment. However, for many patients the cause of stroke remains unknown. Risk factor profile and etiology differ in young and elderly ischemic stroke patients, and atherosclerosis is the determined underlying condition in 10 to 15%. However, subclinical atherosclerosis is probably more prevalent and may go unrecognized. Ultrasound imaging is a sensitive method for the detection of arterial disease and for measurement of adipose tissue. The relationship between intima-media thickness (IMT), plaques, cardiovascular risk factors including visceral adipose tissue (VAT) and ischemic events has repeatedly been shown. We have established The Norwegian Stroke in the Young Study (NOR-SYS) as a three-generation research program with the goal to increase our knowledge on heredity and the development of arterial disease and ischemic stroke. Extended standardized ultrasound examinations are done in order to find subclinical vessel disease for early and better prophylaxis. NOR-SYS is a prospective long-term research program. Standardized methods are used for anamnestic, clinical, laboratory, imaging, and ultrasound data collection in ischemic stroke patients aged ≤60 years, their partners and joint adult offspring. The ultrasound protocol includes the assessment of intracranial, carotid and femoral arteries, abdominal aorta, and the estimation of VAT. To date, the study is a single centre study with approximately 400 patients, 250 partners and 350 adult offspring expected to be recruited at our site. NOR-SYS aims to increase our knowledge about heredity and the development of arterial vascular disease in young patients with ischemic stroke and their families. Moreover, optimization of diagnostics, prophylaxis and early intervention are major targets with the intention to reduce stroke recurrence and other clinical arterial events, physical disability, cognitive impairment and death. NOR-SYS is reviewed and approved by the Regional Committee for Medical and Health Research Ethics, Western-Norway (REK-Vest 2010/74), and registered in ClinicalTrials.gov: NCT01597453.


    • 1 June 2010
      • Vol. 51  (3) , 443-8

    Improved patency and reduced intimal hyperplasia in PTFE grafts with luminal immobilized heparin compared with standard PTFE grafts at six months in a sheep model.

    by G Pedersen, E Laxdal, V Ellensen, T Jonung, E Mattsson

    The aim of this study was to compare the performance of polytetrafluoroethylene (PTFE) grafts with luminal coating of immobilized heparin to that of standard PTFE grafts at six months. Twenty-eight common carotid arteries in fourteen sheep were bypassed with heparin-coated PTFE grafts (6 mm diameter, 6 cm length) on one side and standard PTFE grafts on the other. The grafts were explanted after six months. The thickness of intimal hyperplasia (IH) in open grafts was measured with histomorphometrical methods. Two of 14 heparinized PTFE grafts and nine of 14 grafts in the control PTFE-group were occluded at explantation (P=0.006). Six-month patency rates for heparinized PTFE grafts and for standard PTFE grafts were 86% and 36%, respectively. Mean graft anastomotic IH thickness in open grafts were 0.074 mm for heparinized PTFE grafts and 0.259 mm for PTFE-grafts (P=0.006). PTFE grafts with luminal coating containing immobilized heparin had significantly better patency and recruited less intimal hyperplasia than standard PTFE grafts at six months.


  • Neutrophil CD64 as a Marker for Postoperative Infection: A Pilot Study

    by A. Daryapeyma, G. Pedersen, E. Laxdal, M. Corbascio, H.B. Johannessen, S. Aune, T. Jonung


    • 1 September 2007
      • Vol. 26  (3) , 228-32

    Has endovascular aneurysm repair improved outcome for patients with asymptomatic abdominal aortic aneurysm?

    by S Aune, G Pedersen, E Laxdal, J Wirshing, G Jensen, S Amundsen

    The aim of this study was to compare risk factors, complications, operative mortality and relative survival of patients treated with endovascular aneurysm repair (EVAR) for asymptomatic abdominal aortic aneurysm (AAA) to that of those subjected to open operation. University Hospital. A total of 118 EVAR patients were compared with 386 with open repair during the period from 1995 through 2005, in a single center retrospective study. The two groups had similar risk profiles. EVAR patients were older and had shorter hospital stays than those with open operation. Throughout follow-up, 45.8% of EVAR patients had complications, as compared to only 26% of open repairs. Operative mortality, long-term survival and relative survival did not differ significantly between the two groups. EVAR appears initially safe in selected patients. The complication rate after EVAR is high, but declines throughout the study period. Focus must still be on patient selection and device improvement to reduce complications. The question whether EVAR has improved AAA treatment remains to be answered.